A holistic approach to obesity management is essential, encompassing nutrition counseling, regular exercise, behavioral strategies, and diabetes self-management education to ensure effective and sustainable results.

In people with type 2 diabetes and overweight or obesity, weight management should represent a primary goal of treatment along with glycemic management.

  • Delays progression from prediabetes to type 2 diabetes

  • Is highly beneficial in treating type 2 diabetes

  • Improves glycemia and reduces the need for glucose-lowering medications

  • Reduces cardiovascular risk factors, lowering long-term cardiovascular and mortality risks

  • Reduces other obesity-related health risks

  • Use person-centered, nonjudgmental, person-first language (e.g., “person with diabetes” rather than “diabetic person” and “person with obesity” rather than “obese person”).

  • Calculate BMI and perform measures body fat distribution (e.g., waist circumference, waist-to-hip ratio, and/or waist-to-height ratio).

  • Monitor obesity-related parameters at least annually to guide treatment decisions.

BMI (kg/m²)
25.0–26.9 (or 23.0–24.9*)27.0–29.9 (or 25.0–27.4*)≥30.0 (or ≥27.5*)
Intensive behavioral counseling                 
Obesity pharmacotherapy            
Metabolic surgery       
BMI (kg/m²)
25.0–26.9 (or 23.0–24.9*)27.0–29.9 (or 25.0–27.4*)≥30.0 (or ≥27.5*)
Intensive behavioral counseling                 
Obesity pharmacotherapy            
Metabolic surgery       
*

Recommended cut points for Asian American individuals.

Recommendations

 
Nutrition, physical activity, and behavioral therapy to achieve and maintain ≥5% weight loss are recommended for people with type 2 diabetes and overweight or obesity. 

 
Frequent counseling (≥16 sessions in 6 months) focusing on nutrition, exercise, and behavioral strategies to achieve a 500–750 kcal/day energy deficit, is beneficial for weight loss and recommended if available. 

 
Long-term (≥1 year) weight maintenance programs are advised for those meeting weight loss goals, offering monthly support, weekly body weight monitoring, self-monitoring strategies, and regular physical activity (200–300 min/week). 

 
Short-term, structured very-low-calorie diets (800–1,000 kcal/day) should be reserved for select individuals, prescribed by trained practitioners in medical settings with close monitoring, and include counseling for long-term weight maintenance. 

 
When developing a plan of care, consider systemic, structural, and socioeconomic factors that may affect nutrition patterns and food choices, such as food insecurity and hunger, access to healthful food options, cultural circumstances, and other social determinants of health. 
Recommendations

 
Nutrition, physical activity, and behavioral therapy to achieve and maintain ≥5% weight loss are recommended for people with type 2 diabetes and overweight or obesity. 

 
Frequent counseling (≥16 sessions in 6 months) focusing on nutrition, exercise, and behavioral strategies to achieve a 500–750 kcal/day energy deficit, is beneficial for weight loss and recommended if available. 

 
Long-term (≥1 year) weight maintenance programs are advised for those meeting weight loss goals, offering monthly support, weekly body weight monitoring, self-monitoring strategies, and regular physical activity (200–300 min/week). 

 
Short-term, structured very-low-calorie diets (800–1,000 kcal/day) should be reserved for select individuals, prescribed by trained practitioners in medical settings with close monitoring, and include counseling for long-term weight maintenance. 

 
When developing a plan of care, consider systemic, structural, and socioeconomic factors that may affect nutrition patterns and food choices, such as food insecurity and hunger, access to healthful food options, cultural circumstances, and other social determinants of health. 

  • Consider weight when choosing glucose-lowering medications for individuals with type 2 diabetes and overweight or obesity.

  • When possible, avoid prescribing medications that cause weight gain to treat comorbid conditions.

  • Obesity pharmacotherapy should be considered for people with diabetes and overweight or obesity along with lifestyle changes. Potential benefits and risks must be considered.

  • Continue obesity pharmacotherapy if it is effective (>5% weight loss after 3 months).

  • Consider changing or stopping treatment if weight loss is <5% after 3 months or if significant safety/tolerability issues arise.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/journals/pages/license.